The economics of end-stage renal disease care in Canada: incentives and impact on delivery of care

  • Braden J. Manns
  • David C. Mendelssohn
  • Kenneth J. Taub

DOI: 10.1007/s10754-007-9022-y

Cite this article as:
Manns, B.J., Mendelssohn, D.C. & Taub, K.J. Int J Health Care Finance Econ (2007) 7: 149. doi:10.1007/s10754-007-9022-y


Examining international differences in health outcomes for end-stage renal disease (ESRD) patients requires an understanding of ESRD funding structures. In Canada, funding for all aspects of dialysis and transplant care, with the exception of drugs (for which supplementary insurance can be purchased), is provided for all citizens. Although ESRD programs across Canada’s 10 provinces differ in funding structure, they share important economic characteristics, including being publicly funded and universal, and providing most facets of ESRD care for free. This paper explains how ESRD care fits into the Canadian health care system, describes the epidemiology of ESRD in Canada, and offers economic explanations for international discrepancies.


End-stage renal disease Dialysis Health care financing Medical costs Reimbursement Canada 

JEL Classification

I10 I11 I12 I18 

Copyright information

© Springer Science+Business Media, LLC 2007

Authors and Affiliations

  • Braden J. Manns
    • 1
    • 2
    • 3
  • David C. Mendelssohn
    • 4
  • Kenneth J. Taub
    • 1
  1. 1.Department of MedicineUniversity of CalgaryCalgaryCanada
  2. 2.Department of Community Health SciencesUniversity of CalgaryCalgaryCanada
  3. 3.Institute of Health EconomicsEdmontonCanada
  4. 4.Humber River Regional HospitalUniversity of TorontoWestonCanada

Personalised recommendations